Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Modeling psychiatric disorders through reprogramming.

Brennand KJ, Gage FH.

Dis Model Mech. 2012 Jan;5(1):26-32. doi: 10.1242/dmm.008268. Epub 2011 Oct 4. Review.

PMID:
21954066
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Modeling psychiatric disorders at the cellular and network levels.

Brennand KJ, Simone A, Tran N, Gage FH.

Mol Psychiatry. 2012 Dec;17(12):1239-53. doi: 10.1038/mp.2012.20. Epub 2012 Apr 3. Review.

PMID:
22472874
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.

Brennand KJ, Gage FH.

Stem Cells. 2011 Dec;29(12):1915-22. doi: 10.1002/stem.762. Review.

PMID:
22009633
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Implications and limitations of cellular reprogramming for psychiatric drug development.

Tobe BT, Brandel MG, Nye JS, Snyder EY.

Exp Mol Med. 2013 Nov 15;45:e59. doi: 10.1038/emm.2013.124. Review.

PMID:
24232258
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Human disease modeling with induced pluripotent stem cells.

Trounson A, Shepard KA, DeWitt ND.

Curr Opin Genet Dev. 2012 Oct;22(5):509-16. doi: 10.1016/j.gde.2012.07.004. Epub 2012 Aug 3. Review.

PMID:
22868174
[PubMed - indexed for MEDLINE]
6.

Pluripotent stem cells as a model to study oxygen metabolism in neurogenesis and neurodevelopmental disorders.

Paulsen Bda S, da Silveira MS, Galina A, Rehen SK.

Arch Biochem Biophys. 2013 Jun;534(1-2):3-10. doi: 10.1016/j.abb.2012.10.009. Epub 2012 Oct 27. Review.

PMID:
23111185
[PubMed - indexed for MEDLINE]
7.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

PMID:
21495962
[PubMed - indexed for MEDLINE]
8.

A blueprint for engineering cell fate: current technologies to reprogram cell identity.

Morris SA, Daley GQ.

Cell Res. 2013 Jan;23(1):33-48. doi: 10.1038/cr.2013.1. Epub 2013 Jan 1. Review.

PMID:
23277278
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders.

Chamberlain SJ, Li XJ, Lalande M.

Neurogenetics. 2008 Oct;9(4):227-35. doi: 10.1007/s10048-008-0147-z. Epub 2008 Sep 13. Review.

PMID:
18791750
[PubMed - indexed for MEDLINE]
10.

Reprogramming adult hematopoietic cells.

Kaneko S, Otsu M, Nakauchi H.

Curr Opin Hematol. 2010 Jul;17(4):271-5. doi: 10.1097/MOH.0b013e32833a25ee. Review.

PMID:
20571391
[PubMed - indexed for MEDLINE]
11.

The path from skin to brain: generation of functional neurons from fibroblasts.

Abdullah AI, Pollock A, Sun T.

Mol Neurobiol. 2012 Jun;45(3):586-95. doi: 10.1007/s12035-012-8277-6. Epub 2012 May 22. Review.

PMID:
22614130
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.

Qiang L, Fujita R, Abeliovich A.

Neuron. 2013 Jun 19;78(6):957-69. doi: 10.1016/j.neuron.2013.06.002. Review.

PMID:
23791192
[PubMed - indexed for MEDLINE]
Free Article
13.

Reprogramming of somatic cells.

Rajasingh J.

Prog Mol Biol Transl Sci. 2012;111:51-82. doi: 10.1016/B978-0-12-398459-3.00003-4. Review.

PMID:
22917226
[PubMed - indexed for MEDLINE]
14.

Cellular reprogramming: recent advances in modeling neurological diseases.

Ming GL, Brüstle O, Muotri A, Studer L, Wernig M, Christian KM.

J Neurosci. 2011 Nov 9;31(45):16070-5. doi: 10.1523/JNEUROSCI.4218-11.2011. Review.

PMID:
22072658
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Progress made in the reprogramming field: new factors, new strategies and a new outlook.

Hussein SM, Nagy AA.

Curr Opin Genet Dev. 2012 Oct;22(5):435-43. doi: 10.1016/j.gde.2012.08.007. Epub 2012 Sep 5. Review.

PMID:
22959308
[PubMed - indexed for MEDLINE]
16.

Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration.

Illich DJ, Demir N, Stojković M, Scheer M, Rothamel D, Neugebauer J, Hescheler J, Zöller JE.

Stem Cells. 2011 Apr;29(4):555-63. doi: 10.1002/stem.611. Review.

PMID:
21308867
[PubMed - indexed for MEDLINE]
Free Article
17.

Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells.

Tobe BT, Snyder EY, Nye JS.

Curr Opin Pharmacol. 2011 Oct;11(5):521-7. doi: 10.1016/j.coph.2011.05.007. Epub 2011 Jun 29. Review.

PMID:
21723195
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.

Parameswaran S, Balasubramanian S, Rao MS, Ahmad I.

Stem Cells. 2011 Jul;29(7):1013-20. doi: 10.1002/stem.655. Review.

PMID:
21544901
[PubMed - indexed for MEDLINE]
Free Article
19.

Telomere rejuvenation during nuclear reprogramming.

Marión RM, Blasco MA.

Curr Opin Genet Dev. 2010 Apr;20(2):190-6. doi: 10.1016/j.gde.2010.01.005. Epub 2010 Feb 20. Review.

PMID:
20176474
[PubMed - indexed for MEDLINE]
20.

Resetting epigenetic signatures to induce somatic cell reprogramming.

Lluis F, Cosma MP.

Cell Mol Life Sci. 2013 Apr;70(8):1413-24. doi: 10.1007/s00018-012-1137-8. Epub 2012 Aug 30. Review.

PMID:
22932957
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk